Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toos Daemen

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Iscience|October 13, 2025
Alphavirus replicons encoding IFN-γ enhance cancer virotherapy by overcoming macrophage-mediated suppressionLaura Horvathova, Priscilla Kinderman, Thijs Janzen, et al.
Oncoimmunology|October 6, 2018
Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigensStephanie van de Wall, Karl Ljungberg, Peng Peng Ip, et al.
Angewandte Chemie (International Ed. in English)|August 28, 2023
Histone Deacetylase 3-Directed PROTACs Have Anti-inflammatory Potential by Blocking Polarization of M0-like into M1-like MacrophagesChunlong Zhao, Shipeng Chen, Deng Chen, et al.
International Journal of Cancer|August 8, 2013
Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combinationOana Draghiciu, Mateusz Walczak, Baukje Nynke Hoogeboom, et al.
Expert Review of Vaccines|December 9, 2014
The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspectiveDidik Setiawan, Jos Luttjeboer, Tjalke Arend Westra, et al.
Vaccine|April 11, 2008
The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activityArjan de Mare, Laura B Bungener, Joke Regts, et al.
Gynecologic Oncology|June 24, 2008
Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulationNinke Leffers, Annechien J A Lambeck, Pauline de Graeff, et al.
The Cochrane Database of Systematic Reviews|September 11, 2018
Antigen-specific active immunotherapy for ovarian cancerSterre T Paijens, Ninke Leffers, Toos Daemen, et al.
The Journal of Infectious Diseases|May 2, 2003
HLA class I alleles and cervical neoplasiaJeroen T J Visser, Baukje Nynke Hoogeboom, Nathalie Reesink-Peters, et al.
BMC Infectious Diseases|February 9, 2013
Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the NetherlandsTjalke A Westra, Irina Stirbu-Wagner, Sara Dorsman, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Iscience|October 13, 2025
Alphavirus replicons encoding IFN-γ enhance cancer virotherapy by overcoming macrophage-mediated suppressionLaura Horvathova, Priscilla Kinderman, Thijs Janzen, et al.
Oncoimmunology|October 6, 2018
Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigensStephanie van de Wall, Karl Ljungberg, Peng Peng Ip, et al.
Angewandte Chemie (International Ed. in English)|August 28, 2023
Histone Deacetylase 3-Directed PROTACs Have Anti-inflammatory Potential by Blocking Polarization of M0-like into M1-like MacrophagesChunlong Zhao, Shipeng Chen, Deng Chen, et al.
International Journal of Cancer|August 8, 2013
Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combinationOana Draghiciu, Mateusz Walczak, Baukje Nynke Hoogeboom, et al.
Expert Review of Vaccines|December 9, 2014
The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspectiveDidik Setiawan, Jos Luttjeboer, Tjalke Arend Westra, et al.
Vaccine|April 11, 2008
The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activityArjan de Mare, Laura B Bungener, Joke Regts, et al.
Gynecologic Oncology|June 24, 2008
Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulationNinke Leffers, Annechien J A Lambeck, Pauline de Graeff, et al.
The Cochrane Database of Systematic Reviews|September 11, 2018
Antigen-specific active immunotherapy for ovarian cancerSterre T Paijens, Ninke Leffers, Toos Daemen, et al.
The Journal of Infectious Diseases|May 2, 2003
HLA class I alleles and cervical neoplasiaJeroen T J Visser, Baukje Nynke Hoogeboom, Nathalie Reesink-Peters, et al.
BMC Infectious Diseases|February 9, 2013
Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the NetherlandsTjalke A Westra, Irina Stirbu-Wagner, Sara Dorsman, et al.
Pageof 9